About Index Trending news
Lists
Pricing
Arsanis

Arsanis

Arsanis

Arsanis is a biotechnology company dedicated to the development

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Employees

Team size

10+
Locations
HQ
Xconomy

Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug

Health Funding
$45,500,000 Venture capital (Series D)
PE Hub

Arsanis nabs $45.5 mln Series D

Funding Messaging Data leaks
$9,300,000 Grant
GEN

Arsanis Licenses Adimab RSV Antibodies and Wins $9.3M from Bill & Melinda Gates Foundation Genetic Engineering & Biotechnology News - Biotech from Bench to Business